Global Long-acting Injectable Medications Market Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
At the beginning of 2020, COVID-19 disease began to spread around the world, millions of people worldwide were infected with COVID-19 disease, and major countries around the world have implemented foot prohibitions and work stoppage orders. Except for the medical supplies and life support products industries, most industries have been greatly impacted, and Long-acting Injectable Medications industries have also been greatly affected.
In the past few years, the Long-acting Injectable Medications market experienced a growth of xx, the global market size of Long-acting Injectable Medications reached xx million $ in 2020, of what is about xx million $ in 2015.
From 2015 to 2019, the growth rate of global Long-acting Injectable Medications market size was in the range of xxx%. At the end of 2019, COVID-19 began to erupt in China, Due to the huge decrease of global economy; we forecast the growth rate of global economy will show a decrease of about 4%, due to this reason, Long-acting Injectable Medications market size in 2020 will be xx with a growth rate of xxx%. This is xxx percentage points lower than in previous years.
As of the date of the report, there have been more than 20 million confirmed cases of CVOID-19 worldwide, and the epidemic has not been effectively controlled. Therefore, we predict that the global epidemic will be basically controlled by the end of 2020 and the global Long-acting Injectable Medications market size will reach xx million $ in 2025, with a CAGR of xxx% between 2020-2025.
This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.
Section 1: Free——Definition
Section (2 3): 1200 USD——Manufacturer Detail
Eli Lilly
Alkermes
Johnson & Johnson
Zogenix
DURECT
Mapi Pharma
GSK
MedinCell
Oakwood Labs
Nanomi
Pharmathen
Kashiv BioSciences
Section 4: 900 USD——Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7): 500 USD——
Product Type Segmentation
First-generation
Second-generation
Industry Segmentation
Schizophrenia
Contraception
HIV
Channel (Direct Sales, Distributor) Segmentation
Section 8: 400 USD——Trend (2020-2025)
Section 9: 300 USD——Product Type Detail
Section 10: 700 USD——Downstream Consumer
Section 11: 200 USD——Cost Structure
Section 12: 500 USD——Conclusion
Section 1 Long-acting Injectable Medications Product Definition
Section 2 Global Long-acting Injectable Medications Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Long-acting Injectable Medications Shipments
2.2 Global Manufacturer Long-acting Injectable Medications Business Revenue
2.3 Global Long-acting Injectable Medications Market Overview
2.4 COVID-19 Impact on Long-acting Injectable Medications Industry
Section 3 Manufacturer Long-acting Injectable Medications Business Introduction
3.1 Eli Lilly Long-acting Injectable Medications Business Introduction
3.1.1 Eli Lilly Long-acting Injectable Medications Shipments, Price, Revenue and Gross profit 2015-2020
3.1.2 Eli Lilly Long-acting Injectable Medications Business Distribution by Region
3.1.3 Eli Lilly Interview Record
3.1.4 Eli Lilly Long-acting Injectable Medications Business Profile
3.1.5 Eli Lilly Long-acting Injectable Medications Product Specification
3.2 Alkermes Long-acting Injectable Medications Business Introduction
3.2.1 Alkermes Long-acting Injectable Medications Shipments, Price, Revenue and Gross profit 2015-2020
3.2.2 Alkermes Long-acting Injectable Medications Business Distribution by Region
3.2.3 Interview Record
3.2.4 Alkermes Long-acting Injectable Medications Business Overview
3.2.5 Alkermes Long-acting Injectable Medications Product Specification
3.3 Johnson & Johnson Long-acting Injectable Medications Business Introduction
3.3.1 Johnson & Johnson Long-acting Injectable Medications Shipments, Price, Revenue and Gross profit 2015-2020
3.3.2 Johnson & Johnson Long-acting Injectable Medications Business Distribution by Region
3.3.3 Interview Record
3.3.4 Johnson & Johnson Long-acting Injectable Medications Business Overview
3.3.5 Johnson & Johnson Long-acting Injectable Medications Product Specification
3.4 Zogenix Long-acting Injectable Medications Business Introduction
3.5 DURECT Long-acting Injectable Medications Business Introduction
3.6 Mapi Pharma Long-acting Injectable Medications Business Introduction
…
Section 4 Global Long-acting Injectable Medications Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Long-acting Injectable Medications Market Size and Price Analysis 2015-2020
4.1.2 Canada Long-acting Injectable Medications Market Size and Price Analysis 2015-2020
4.2 South America Country
4.2.1 South America Long-acting Injectable Medications Market Size and Price Analysis 2015-2020
4.3 Asia Country
4.3.1 China Long-acting Injectable Medications Market Size and Price Analysis 2015-2020
4.3.2 Japan Long-acting Injectable Medications Market Size and Price Analysis 2015-2020
4.3.3 India Long-acting Injectable Medications Market Size and Price Analysis 2015-2020
4.3.4 Korea Long-acting Injectable Medications Market Size and Price Analysis 2015-2020
4.4 Europe Country
4.4.1 Germany Long-acting Injectable Medications Market Size and Price Analysis 2015-2020
4.4.2 UK Long-acting Injectable Medications Market Size and Price Analysis 2015-2020
4.4.3 France Long-acting Injectable Medications Market Size and Price Analysis 2015-2020
4.4.4 Italy Long-acting Injectable Medications Market Size and Price Analysis 2015-2020
4.4.5 Europe Long-acting Injectable Medications Market Size and Price Analysis 2015-2020
4.5 Other Country and Region
4.5.1 Middle East Long-acting Injectable Medications Market Size and Price Analysis 2015-2020
4.5.2 Africa Long-acting Injectable Medications Market Size and Price Analysis 2015-2020
4.5.3 GCC Long-acting Injectable Medications Market Size and Price Analysis 2015-2020
4.6 Global Long-acting Injectable Medications Market Segmentation (Region Level) Analysis 2015-2020
4.7 Global Long-acting Injectable Medications Market Segmentation (Region Level) Analysis
Section 5 Global Long-acting Injectable Medications Market Segmentation (Product Type Level)
5.1 Global Long-acting Injectable Medications Market Segmentation (Product Type Level) Market Size 2015-2020
5.2 Different Long-acting Injectable Medications Product Type Price 2015-2020
5.3 Global Long-acting Injectable Medications Market Segmentation (Product Type Level) Analysis
Section 6 Global Long-acting Injectable Medications Market Segmentation (Industry Level)
6.1 Global Long-acting Injectable Medications Market Segmentation (Industry Level) Market Size 2015-2020
6.2 Different Industry Price 2015-2020
6.3 Global Long-acting Injectable Medications Market Segmentation (Industry Level) Analysis
Section 7 Global Long-acting Injectable Medications Market Segmentation (Channel Level)
7.1 Global Long-acting Injectable Medications Market Segmentation (Channel Level) Sales Volume and Share 2015-2020
7.2 Global Long-acting Injectable Medications Market Segmentation (Channel Level) Analysis
Section 8 Long-acting Injectable Medications Market Forecast 2020-2025
8.1 Long-acting Injectable Medications Segmentation Market Forecast (Region Level)
8.2 Long-acting Injectable Medications Segmentation Market Forecast (Product Type Level)
8.3 Long-acting Injectable Medications Segmentation Market Forecast (Industry Level)
8.4 Long-acting Injectable Medications Segmentation Market Forecast (Channel Level)
Section 9 Long-acting Injectable Medications Segmentation Product Type
9.1 First-generation Product Introduction
9.2 Second-generation Product Introduction
Section 10 Long-acting Injectable Medications Segmentation Industry
10.1 Schizophrenia Clients
10.2 Contraception Clients
10.3 HIV Clients
Section 11 Long-acting Injectable Medications Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview
Section 12 Conclusion
Chart and Figure
Figure Long-acting Injectable Medications Product Picture from Eli Lilly
Chart 2015-2020 Global Manufacturer Long-acting Injectable Medications Shipments (Units)
Chart 2015-2020 Global Manufacturer Long-acting Injectable Medications Shipments Share
Chart 2015-2020 Global Manufacturer Long-acting Injectable Medications Business Revenue (Million USD)
Chart 2015-2020 Global Manufacturer Long-acting Injectable Medications Business Revenue Share
Chart Eli Lilly Long-acting Injectable Medications Shipments, Price, Revenue and Gross profit 2015-2020
Chart Eli Lilly Long-acting Injectable Medications Business Distribution
Chart Eli Lilly Interview Record (Partly)
Figure Eli Lilly Long-acting Injectable Medications Product Picture
Chart Eli Lilly Long-acting Injectable Medications Business Profile
Table Eli Lilly Long-acting Injectable Medications Product Specification
Chart Alkermes Long-acting Injectable Medications Shipments, Price, Revenue and Gross profit 2015-2020
Chart Alkermes Long-acting Injectable Medications Business Distribution
Chart Alkermes Interview Record (Partly)
Figure Alkermes Long-acting Injectable Medications Product Picture
Chart Alkermes Long-acting Injectable Medications Business Overview
Table Alkermes Long-acting Injectable Medications Product Specification
Chart Johnson & Johnson Long-acting Injectable Medications Shipments, Price, Revenue and Gross profit 2015-2020
Chart Johnson & Johnson Long-acting Injectable Medications Business Distribution
Chart Johnson & Johnson Interview Record (Partly)
Figure Johnson & Johnson Long-acting Injectable Medications Product Picture
Chart Johnson & Johnson Long-acting Injectable Medications Business Overview
Table Johnson & Johnson Long-acting Injectable Medications Product Specification
3.4 Zogenix Long-acting Injectable Medications Business Introduction
…
Chart United States Long-acting Injectable Medications Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart United States Long-acting Injectable Medications Sales Price ($/Unit) 2015-2020
Chart Canada Long-acting Injectable Medications Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Canada Long-acting Injectable Medications Sales Price ($/Unit) 2015-2020
Chart South America Long-acting Injectable Medications Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart South America Long-acting Injectable Medications Sales Price ($/Unit) 2015-2020
Chart China Long-acting Injectable Medications Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart China Long-acting Injectable Medications Sales Price ($/Unit) 2015-2020
Chart Japan Long-acting Injectable Medications Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Japan Long-acting Injectable Medications Sales Price ($/Unit) 2015-2020
Chart India Long-acting Injectable Medications Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart India Long-acting Injectable Medications Sales Price ($/Unit) 2015-2020
Chart Korea Long-acting Injectable Medications Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Korea Long-acting Injectable Medications Sales Price ($/Unit) 2015-2020
Chart Germany Long-acting Injectable Medications Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Germany Long-acting Injectable Medications Sales Price ($/Unit) 2015-2020
Chart UK Long-acting Injectable Medications Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart UK Long-acting Injectable Medications Sales Price ($/Unit) 2015-2020
Chart France Long-acting Injectable Medications Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart France Long-acting Injectable Medications Sales Price ($/Unit) 2015-2020
Chart Italy Long-acting Injectable Medications Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Italy Long-acting Injectable Medications Sales Price ($/Unit) 2015-2020
Chart Europe Long-acting Injectable Medications Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Europe Long-acting Injectable Medications Sales Price ($/Unit) 2015-2020
Chart Middle East Long-acting Injectable Medications Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Middle East Long-acting Injectable Medications Sales Price ($/Unit) 2015-2020
Chart Africa Long-acting Injectable Medications Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Africa Long-acting Injectable Medications Sales Price ($/Unit) 2015-2020
Chart GCC Long-acting Injectable Medications Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart GCC Long-acting Injectable Medications Sales Price ($/Unit) 2015-2020
Chart Global Long-acting Injectable Medications Market Segmentation (Region Level) Sales Volume 2015-2020
Chart Global Long-acting Injectable Medications Market Segmentation (Region Level) Market size 2015-2020
Chart Long-acting Injectable Medications Market Segmentation (Product Type Level) Volume (Units) 2015-2020
Chart Long-acting Injectable Medications Market Segmentation (Product Type Level) Market Size (Million $) 2015-2020
Chart Different Long-acting Injectable Medications Product Type Price ($/Unit) 2015-2020
Chart Long-acting Injectable Medications Market Segmentation (Industry Level) Market Size (Volume) 2015-2020
Chart Long-acting Injectable Medications Market Segmentation (Industry Level) Market Size (Share) 2015-2020
Chart Long-acting Injectable Medications Market Segmentation (Industry Level) Market Size (Value) 2015-2020
Chart Global Long-acting Injectable Medications Market Segmentation (Channel Level) Sales Volume (Units) 2015-2020
Chart Global Long-acting Injectable Medications Market Segmentation (Channel Level) Share 2015-2020
Chart Long-acting Injectable Medications Segmentation Market Forecast (Region Level) 2020-2025
Chart Long-acting Injectable Medications Segmentation Market Forecast (Product Type Level) 2020-2025
Chart Long-acting Injectable Medications Segmentation Market Forecast (Industry Level) 2020-2025
Chart Long-acting Injectable Medications Segmentation Market Forecast (Channel Level) 2020-2025
Chart First-generation Product Figure
Chart First-generation Product Advantage and Disadvantage Comparison
Chart Second-generation Product Figure
Chart Second-generation Product Advantage and Disadvantage Comparison
Chart Schizophrenia Clients
Chart Contraception Clients
Chart HIV Clients
Research Methodology:
Long acting Injectable Medications Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|